Pfizer Inc. buy Guggenheim
Start price
23.02.24
/
50%
€25.55
Target price
23.02.25
€33.22
Performance (%)
-1.84%
End price
24.02.25
€25.08
Summary
This prediction ended on 24.02.25 with a price of €25.08. With a performance of -1.84%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. A total of €1.58 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -4.262% | -4.262% | 6.474% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten